Hopper got plenty access to liquid cancers via CHM, no need for IMU to develop their own one. But the fast way to get an asset approved looked too tempting. Yes, Acer-Cel could be combined with CF33 but at first needs to be approved. And that financial component was miscalculated, what if IMU can't raise funds or sell / partner AC? That got unfortunately a high possibility. And automatically B-Cell and CF33 get dragged down as well. A complete failure of strategy caused by ?
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)